Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Ra Capital Management
AddedFeb 13, 2024
UpdatedJul 16, 2026
Ra Capital Management

Ra Capital Management

Operating

RA Capital Management: Boston-based investment advisor specializing in life-sciences and drug development.

Location
Boston, MA, US
Founded
2001
Firm
Compare
Portfolio
Employees
Website

RA Capital Management is a Boston-based investment firm specializing in life sciences and drug development. The firm engages in multi-stage investments, including Series A, B, C, and beyond, focusing on companies developing drugs, medical devices, diagnostics, services, and research tools. RA Capital leverages its team's deep expertise in biology, chemistry, and medicine to identify and support promising technologies and products.

Notable portfolio companies include Moderna, Arvinas, and Nimbus Therapeutics. Key partners at RA Capital bring significant industry experience and have held executive and board-level positions. The firm's investment philosophy centers on evidence-based decision-making. RA Capital offers unique value-add services such as strategic guidance, operational support, and access to a broad network of industry experts to help portfolio companies navigate from lab to market.

Ra Capital Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments210
Current Portfolio Count147
Total Portfolio Exits9

Top Investment Stages

Series B62 (36.0%)
Series A42 (24.4%)
Series C35 (20.3%)
Post Ipo Equity19 (11.0%)
Seed14 (8.1%)

Stage Mix

Series B 36%Series A 24%Series C 20%Post Ipo Equity 11%Seed 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Memento Medicines logo

Memento Medicines

SonoThera logo

SonoThera

Astria Therapeutics logo

Astria Therapeutics

Vaxart logo

Vaxart

Claris Biotherapeutics logo

Claris Biotherapeutics

Bicara Therapeutics logo

Bicara Therapeutics

AM Batteries logo

AM Batteries

Arvinas logo

Arvinas

Forward Therapeutics logo

Forward Therapeutics

Rampart Bioscience logo

Rampart Bioscience

Aiolos Bio logo

Aiolos Bio

Amplifier Therapeutics logo

Amplifier Therapeutics

Ventricle Health logo

Ventricle Health

Commons Clinic logo

Commons Clinic

SAB Biotherapeutics logo

SAB Biotherapeutics

Adela logo

Adela

Hyku logo

Hyku

Vaxess Technologies logo

Vaxess Technologies

Mariana Oncology logo

Mariana Oncology

Nimbus Therapeutics logo

Nimbus Therapeutics

Star Therapeutics logo

Star Therapeutics

Sortera Alloys. logo

Sortera Alloys.

Superluminal Medicines logo

Superluminal Medicines

Excepgen logo

Excepgen

Abcuro logo

Abcuro

Ra Capital Management - Similar Investment Firms

RA Capital Advisors logo

RA Capital Advisors

raca.com

Bain Capital Life Sciences logo

Bain Capital Life Sciences

baincapital.com

Rapha Capital Management logo

Rapha Capital Management

raphacap.com

Pappas Capital logo

Pappas Capital

pappas-capital.com

Roth Capital Partners logo

Roth Capital Partners

roth.com

EcoR1 Capital logo

EcoR1 Capital

ecor1cap.com

MPM Capital logo

MPM Capital

mpmbioimpact.com

CaaS Capital Management logo

CaaS Capital Management

caascap.com

Boston Millennia Partners logo

Boston Millennia Partners

RC Capital logo

RC Capital

rccf.com

Roark Capital Group logo

Roark Capital Group

roarkcapital.com

Raptor Group logo

Raptor Group

raptorgroup.com

Rockefeller Capital Management logo

Rockefeller Capital Management

rockco.com

Foresite Capital logo

Foresite Capital

Radius Ventures logo

Radius Ventures

radiusventures.com

Ra Capital Management - Classification

Also Known As
  • RA Capital Management, L.P.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
ISIC
  • 6430Trusts, funds and similar financial entities
Show 5 more industry codes
NAICS
  • 525900Other Investment Pools and Funds
  • 525990Other Financial Vehicles
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6726Unit Investment Trusts, Face-amount Certificate Offices
  • 6000Depository Institutions